We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Digital Outsert | Nov/Dec 2020

Break Free From Tradition with the AcrySof IQ PanOptix Trifocal IOL – Quentin Allen, MD

Quentin Allen, MD, enjoys living life spontaneously—something that can be made difficult by visual restrictions. For Dr. Allen and many of his patients, the freedom to explore the outdoors, go for a drive, or share a meal at a restaurant can be hindered by poor vision. That’s why Dr. Allen chooses the lens that offers a range of vision, keeping you ready for anything: the Alcon AcrySof IQ PanOptix Trifocal IOL.

I broke free from tradition, and my patients are enjoying a newfound freedom.

“To me, freedom means breaking free from restrictions. A patient fitted with a monofocal lens is still going to need glasses for many aspects of everyday life, and they often get frustrated. There’s just a profound loss of accommodation that occurs with a monofocal lens. That’s why I offer the PanOptix Trifocal IOL. It makes intermediate vision possible without compromising near and distance vision.”

Dr. Quentin Allen, MD on Breaking Free:

Like his patients, Quentin B. Allen, MD, enjoys the spontaneity of life and recognizes his patients need the ability to adapt to different situations. With the AcrySof IQ PanOptix® Trifocal IOL by Alcon, Dr. Allen can offer his patients the possibility of obtaining full simultaneous breadth of focus.

To many patients, driving represents a major mode of freedom, but it requires focus at all ranges of vision and keen depth perception in a variety of lighting conditions.

“People don’t realize just how often they use their intermediate vison. They think, ‘Oh I’ll only need my glasses for reading,’ but in reality, we’re engaging our intermediate vision all the time—simple things like browsing a menu, engaging in conversation, or even seeing the food on one’s plate or, more importantly, the gauges on a dashboard.”

In my practice, our mission is to help patients attain the clearest vision possible. As a provider, I’m not satisfied simply switching one restriction for another. It’s time to give our patients one less encumbrance and a lot more freedom.

“Like many of my patients, I enjoy the spontaneity of life, whether it’s getting out and exploring the outdoors or something simple like enjoying a meal with friends or family. To me, it’s about always being ready for what’s next. I want my patients to enjoy that as well.”

AcrySof® IQ PanOptix® Family of Trifocal IOLs


CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ PanOptix® Trifocal IOLs include AcrySof® IQ PanOptix® and AcrySof® IQ PanOptix® Toric and are indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. In addition, the AcrySof® IQ PanOptix® Toric Trifocal IOL is indicated for the reduction of residual refractive astigmatism.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia and ensure that IOL centration is achieved.

For the AcrySof® IQ PanOptix® Toric Trifocal IOL, the lens should not be implanted if the posterior capsule is ruptured, if the zonules are damaged or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation.

Some visual effects may be expected due to the superposition of focused and unfocused multiple images. These may include some perceptions of halos or starbursts, as well as other visual symptoms. As with other multifocal IOLs, there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. A reduction in contrast sensitivity as compared to a monofocal IOL may be experienced by some patients and may be more prevalent in low lighting conditions. Therefore, patients implanted with multifocal IOLs should exercise caution when driving at night or in poor visibility conditions.

Patients should be advised that unexpected outcomes could lead to continued spectacle dependence or the need for secondary surgical intervention (e.g., intraocular lens replacement or repositioning).

As with other multifocal IOLs, patients may need glasses when reading small print or looking at small objects. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than patients with monofocal IOLs. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure, available from Alcon, informing them of possible risks and benefits associated with the AcrySof® IQ PanOptix® Trifocal IOLs.

ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions.

*Based on mean value of binocular defocus curve at near, intermediate and distance at 6 months (n=127).

†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.

1. AcrySof® IQ PanOptix® Directions for Use.


© 2020 Alcon Inc. 11/20

PanOptix is a trademark of Alcon. All other brand/product names are the trademarks of their respective owners.